These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28514307)

  • 1. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review.
    Li N; Xu Y; Li G; Yu T; Yao RE; Wang X; Wang J
    Medicine (Baltimore); 2017 May; 96(20):e6914. PubMed ID: 28514307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report.
    Winczewska-Wiktor A; Badura-Stronka M; Monies-Nowicka A; Nowicki MM; Steinborn B; Latos-Bieleńska A; Monies D
    BMC Neurol; 2016 Mar; 16():35. PubMed ID: 26968164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability.
    Dashti S; Salehpour S; Ghasemi MR; Sadeghi H; Rostami M; Hashemi-Gorji F; Mirfakhraie R; Yassaee VR; Miryounesi M
    Neurol Sci; 2022 Apr; 43(4):2859-2863. PubMed ID: 35099645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.
    Kuechler A; Willemsen MH; Albrecht B; Bacino CA; Bartholomew DW; van Bokhoven H; van den Boogaard MJ; Bramswig N; Büttner C; Cremer K; Czeschik JC; Engels H; van Gassen K; Graf E; van Haelst M; He W; Hogue JS; Kempers M; Koolen D; Monroe G; de Munnik S; Pastore M; Reis A; Reuter MS; Tegay DH; Veltman J; Visser G; van Hasselt P; Smeets EE; Vissers L; Wieland T; Wissink W; Yntema H; Zink AM; Strom TM; Lüdecke HJ; Kleefstra T; Wieczorek D
    Hum Genet; 2015 Jan; 134(1):97-109. PubMed ID: 25326669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency.
    Dubruc E; Putoux A; Labalme A; Rougeot C; Sanlaville D; Edery P
    Am J Med Genet A; 2014 Jun; 164A(6):1571-5. PubMed ID: 24668549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense variants in CTNNB1 can be associated with vitreoretinopathy-Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype.
    Rossetti LZ; Bekheirnia MR; Lewis AM; Mefford HC; Golden-Grant K; Tarczy-Hornoch K; Briere LC; Sweetser DA; Walker MA; Kravets E; Stevenson DA; Bruenner G; Sebastian J; Knapo J; Rosenfeld JA; Marcogliese PC; ; Wangler MF
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1542. PubMed ID: 33350591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals.
    Kharbanda M; Pilz DT; Tomkins S; Chandler K; Saggar A; Fryer A; McKay V; Louro P; Smith JC; Burn J; Kini U; De Burca A; FitzPatrick DR; Kinning E;
    Eur J Med Genet; 2017 Feb; 60(2):130-135. PubMed ID: 27915094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Phenotype and Genotype in CTNNB1 Syndrome: A Systematic Review of the Literature.
    Miroševič Š; Khandelwal S; Sušjan P; Žakelj N; Gosar D; Forstnerič V; Lainšček D; Jerala R; Osredkar D
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects.
    Wang H; Zhao Y; Yang L; Han S; Qi M
    Neurol Sci; 2019 Aug; 40(8):1701-1704. PubMed ID: 30929091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characteristics of 24 mainland Chinese patients with CTNNB1 loss-of-function variants.
    Yan D; Sun Y; Xu N; Yu Y; Zhan Y;
    Mol Genet Genomic Med; 2022 Nov; 10(11):e2067. PubMed ID: 36153650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Exudative Vitreoretinopathy and Systemic Abnormalities in Patients With CTNNB1 Mutations.
    Huang L; Lu J; Wang Y; Sun L; Ding X
    Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):18. PubMed ID: 36790797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia.
    Taylor RL; Soriano CS; Williams S; Dzulova D; Ashworth J; Hall G; Gale T; Lloyd IC; Inglehearn CF; Toomes C; Douzgou S; Black GC
    Orphanet J Rare Dis; 2022 Mar; 17(1):110. PubMed ID: 35246174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTNNB1 (β-CATENIN) VITREORETINOPATHY: IMAGING CHARACTERISTICS AND SURGICAL MANAGEMENT.
    Tipsuriyaporn B; Ammar MJ; Yonekawa Y
    Retin Cases Brief Rep; 2022 May; 16(3):259-262. PubMed ID: 32150115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder.
    Sudnawa KK; Garber A; Cohen R; Calamia S; Kanner CH; Montes J; Bain JM; Fee RJ; Chung WK
    Clin Genet; 2024 May; 105(5):523-532. PubMed ID: 38247296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.
    Arboleda VA; Lee H; Dorrani N; Zadeh N; Willis M; Macmurdo CF; Manning MA; Kwan A; Hudgins L; Barthelemy F; Miceli MC; Quintero-Rivera F; Kantarci S; Strom SP; Deignan JL; ; Grody WW; Vilain E; Nelson SF
    Am J Hum Genet; 2015 Mar; 96(3):498-506. PubMed ID: 25728775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole Exome Sequencing Identified two Novel Truncation Mutations in the
    Ji Y; Xia Q; Zhang H; Huo H; Cao X; Wang W; Gu Q
    Child Neurol Open; 2023; 10():2329048X231184184. PubMed ID: 37560515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
    Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
    BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTNNB1 gene mutation associated with neurodevelopmental disorder, microcephaly, and persistence of bilateral hyperplastic primary vitreous: A case report and literature review.
    Zuluaga Gómez LM; Caballero Mojica SC; Vélez Rengifo GJ; Bravo Acosta JD; Montoya Villada JH
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Jan; 97(1):44-47. PubMed ID: 35027145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygous CTNNB1 and TBX4 variants in a patient with abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity.
    Karolak JA; Szafranski P; Kilner D; Patel C; Scurry B; Kinning E; Chandler K; Jhangiani SN; Coban Akdemir ZH; Lupski JR; Popek E; Stankiewicz P
    Clin Genet; 2019 Oct; 96(4):366-370. PubMed ID: 31309540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: A
    Ke Z; Chen Y
    Front Pediatr; 2020; 8():575673. PubMed ID: 33425807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.